TP53 and lung cancer: Zhou et al. [159] developed ROS-responsive oligomer-based polymeric NPs (dihydrolipoic acid, o-DHLA) to deliver p53 mRNA and indocyanine green (ICG), demonstrating synergistic therapeutic effects for lung cancer.